A Phase 1 Open-Label Study With Oral TR-701 Free Acid to Assess Pharmacokinetics, Safety, and Tolerability in Elderly Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2018
At a glance
- Drugs Tedizolid (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- Sponsors Trius Therapeutics
- 01 Jan 2018 Results assessing pharmacokinetics, safety and tolerability published in the Clinical Pharmacology in Drug Development.
- 04 Jun 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 04 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.